TherapeuticsMD | TXMD - Operating Expenses


TherapeuticsMD reported $1.41M in Operating Expenses for its fiscal quarter ending in June of 2024.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Alterity Therapeutics Limited AUD 7.78M 3M Jun/2023
Cipla INR 60.98B 1.06B Dec/2025
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 9.78M 90K Sep/2025
CSL USD 5.7B 2.82B Dec/2025
Grifols EUR 1.77B 22.04M Sep/2025
Novo Nordisk DKK 6.5B 32.8B Jun/2025
Pfizer USD 12.91B 79.89B Dec/2025
TherapeuticsMD USD 1.41M 50K Jun/2024